Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001641172-25-003118

CEO and CFO bought 3,600 shares at $9.10 ($32,760)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-04-07 Purchase +3,600 $9.10 $32,760 5,561,602 D: show line 1 in the form
Open-market purchases · 3,600 sh · avg $9.10 · $32,760
Loading xslF345X05/ownership.xml…